| Title : Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study - Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_ |
| Author(s) : Thompson W , Yu B , Porter J , Fang J , Ferreira-Legere LE , Austin PC , Jackevicius CA , Ross H , Lee DS , Weisman A , Farkouh ME , Gershon AS , Atzema CL , Kwong JC , Ha A , Dzavik V , Udell JA |
| Ref : BMJ Open Diabetes Res Care , 13 : , 2025 |
| Abstract : |
| PubMedSearch : Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_ |
| PubMedID: 40780839 |
| Title : Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study - Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_ |
| Author(s) : Thompson W , Yu B , Porter J , Fang J , Ferreira-Legere LE , Austin PC , Jackevicius CA , Ross H , Lee DS , Weisman A , Farkouh ME , Gershon AS , Atzema CL , Kwong JC , Ha A , Dzavik V , Udell JA |
| Ref : BMJ Open Diabetes Res Care , 13 : , 2025 |
| Abstract : |
| PubMedSearch : Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_ |
| PubMedID: 40780839 |
| Title : Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study - Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_ |
| Author(s) : Thompson W , Yu B , Porter J , Fang J , Ferreira-Legere LE , Austin PC , Jackevicius CA , Ross H , Lee DS , Weisman A , Farkouh ME , Gershon AS , Atzema CL , Kwong JC , Ha A , Dzavik V , Udell JA |
| Ref : BMJ Open Diabetes Res Care , 13 : , 2025 |
| Abstract : |
| PubMedSearch : Thompson_2025_BMJ.Open.Diabetes.Res.Care_13_ |
| PubMedID: 40780839 |